UK markets close in 8 hours 25 minutes
  • FTSE 100

    7,337.05
    0.00 (0.00%)
     
  • FTSE 250

    23,230.43
    0.00 (0.00%)
     
  • AIM

    1,199.69
    0.00 (0.00%)
     
  • GBP/EUR

    1.1658
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.3202
    -0.0004 (-0.03%)
     
  • BTC-GBP

    37,835.19
    -620.30 (-1.61%)
     
  • CMC Crypto 200

    1,305.05
    -0.07 (-0.01%)
     
  • S&P 500

    4,701.21
    +14.46 (+0.31%)
     
  • DOW

    35,754.75
    +35.32 (+0.10%)
     
  • CRUDE OIL

    72.74
    +0.38 (+0.53%)
     
  • GOLD FUTURES

    1,787.00
    +1.50 (+0.08%)
     
  • NIKKEI 225

    28,725.47
    -135.15 (-0.47%)
     
  • HANG SENG

    24,269.86
    +272.99 (+1.14%)
     
  • DAX

    15,687.09
    -126.81 (-0.80%)
     
  • CAC 40

    7,014.57
    0.00 (0.00%)
     

Global Ocular Drug Delivery Devices Market: Global Market Size, Forecast, Insights, and Competitive Landscape 2021-2027

·2-min read

Dublin, Nov. 19, 2021 (GLOBE NEWSWIRE) -- The "Ocular Drug Delivery Devices Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

The global ocular drug delivery devices market is expected to grow at a CAGR of around 5.3% during 2021-2027.

This report on global ocular drug delivery devices market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.

The report presents a clear picture of the global ocular drug delivery devices market by segmenting the market based on technology, disease, formulation, end users, and region.

Also, detailed profiles of companies operating in the ocular drug delivery devices market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

  • Rising Prevalence of Ophthalmic Diseases

  • Rising Incidence of Glaucoma and Macular Degeneration

  • Increasing Number of Approvals

Market Challenges

  • Post Usage Complications

  • High Prices

Historical & Forecast Period

Base Year: 2020
Historical Period: 2016-2019
Forecast Period: 2021-2027

Market by Technology

  • Topical

  • Iontophoresis

  • Ocular Insert

  • Erodible

  • Non-Erodible

  • Intraocular Implants

  • Biodegradable

  • Non-Biodegradable

  • In Situ Gel & Punctal Plugs

  • Others

Market by Disease

  • Glaucoma

  • Diabetic Retinopathy

  • Dry Eye Syndrome

  • Macular Degeneration

  • Cataract

  • Diabetic Macular Edema

  • Others

Market by Formulation

  • Liposomes & Nanoparticles

  • Solution

  • Emulsion

  • Suspension

  • Ointment

Market by End User

  • Hospitals

  • Ophthalmic Clinics

  • Homecare Settings

  • Ambulatory Surgical Center

Market by Region

  • Europe

  • Germany

  • United Kingdom

  • France

  • Italy

  • Spain

  • Russia

  • Netherlands

  • Rest of Europe

  • North America

  • United States

  • Canada

  • Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Rest of Asia Pacific

  • Latin America

  • Mexico

  • Brazil

  • Argentina

  • Rest of Latin America

  • Middle East & Africa

  • Saudi Arabia

  • Turkey

  • Iran

  • United Arab Emirates

  • Rest of Middle East & Africa

Companies Mentioned

  • Valeant Pharmaceuticals International, Inc

  • Taiwan Liposome Company, Ltd

  • Ocular Therapeutix, Inc

  • Graybug Vision Inc

  • Eyegate Pharma

  • Clearside Biomedical, Inc

  • Alimera Sciences

  • Envisia Therapeutics

  • Allergan, Plc

  • Novar

For more information about this report visit https://www.researchandmarkets.com/r/ceafn

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting